Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
Mount Sinai Researchers Reveal Addiction Defects in the Brain
Researchers from Mount Sinai Hospital have released a study showing brain abnormalities common to heroin and cocaine addicts.
Is Ozempic Shrinking Profits for Snack Food Firms?
The snack food industry is bracing for reduced sales due to GLP-1 drugs such as Ozempic.